Dimy Fluyau

Dimy Fluyau, MD

Addiction Medicine Fellowship Director And Assistant Professor

Department: MD-PSYCHIATRY
Business Phone: (352) 265-4357
Business Email: fluyau.di@ufl.edu

About Dimy Fluyau

My name is Dimy Fluyau, and I am a psychiatry and addiction medicine specialist at UF Health Adult Psychiatry – Springhill. I received my medical degree from the State University of Haiti (Université d’État d’Haïti). I completed my internal medicine residency at the State University of Haiti Hospital (Hôpital de l’Université d’État d’Haïti) and my psychiatry residency at Harlem Hospital Medical Center affiliated with Columbia University, where I was the chief resident. I am board certified in psychiatry and addiction medicine.

Understanding human suffering necessitates first experiencing it. Some of us succumb to it, while others rise. The concept of rising inspired me to become a doctor. A glance back in time can help us understand how others perceive addiction. Translational research and human studies have aided in recognizing addiction as a brain condition, a treatable disorder that is not chastised. I want to treat those suffering from addiction and help advance treatment research. I want my patients to know I will listen to and support them throughout their treatment process.

In 2016, I joined Emory University in Atlanta, Georgia, as a psychiatry and behavioral sciences assistant professor. My clinical duty was at Grady Memorial Hospital in the emergency department. There, I evaluated and treated thousands of patients from diverse backgrounds suffering from mental illnesses and addiction. My academic appointment involved teaching, mentoring, lecturing and supervising Emory and Morehouse psychiatric residents, medical students, physician assistants and nurse practitioners.

I am a member of the American Academy of Addiction Psychiatry (AAAP), the American Psychiatric Association (APA), the World Psychiatric Association (WPA) and the American Medical Association (AMA).

I am involved in leading-edge clinical research in addiction and have published various evidence-based topics using Bayesian and frequentist meta-analytic techniques. Psychopathology also interests me. I have delivered several conference presentations, both nationally and internationally, on addiction and psychiatry.

I can speak and write Spanish, Creole and French. Outside of work, I enjoy sports, traveling, DIY projects, spending quality time with my family and participating in church and community activities.

Board Certifications

  • Addiction Medicine
    American Board of Preventive Medicine
  • Psychiatry
    American Board of Psychiatry and Neurology

Clinical Profile

Specialties
  • Addiction Medicine
  • Psychiatry

Research Profile

Open Researcher and Contributor ID (ORCID)

0000-0002-9272-2259

Areas of Interest
  • Addiction medicine
  • Mental illness
  • Psychopathology

Publications

2023
A Bayesian meta-analysis of topiramate’s effectiveness for individuals with alcohol use disorder
Journal of Psychopharmacology. 37(2):155-163 [DOI] 10.1177/02698811221149643.
2023
Beyond benzodiazepines: a meta-analysis and narrative synthesis of the efficacy and safety of alternative options for alcohol withdrawal syndrome management.
European journal of clinical pharmacology. 79(9):1147-1157 [DOI] 10.1007/s00228-023-03523-2. [PMID] 37380897.
2023
Drug Addiction
StatPearls. [PMID] 31747190.
2023
On the Borderline of Pleasure and Pain: Comorbid Persistent Genital Arousal Disorder and Borderline Personality Disorder.
The primary care companion for CNS disorders. 25(1) [DOI] 10.4088/PCC.22cr03281. [PMID] 36638541.
2023
The Current Role of Medical Simulation in Psychiatry
StatPearls. [PMID] 31869129.
2022
Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis
European Journal of Clinical Pharmacology. 78(6):931-942 [DOI] 10.1007/s00228-022-03303-4.
2021
Pharmacological management of psychoactive substance withdrawal syndrome
Drugs & Therapy Perspectives. 37(11):519-535 [DOI] 10.1007/s40267-021-00874-7.
2021
Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder
The American Journal on Addictions. 30(2):110-121 [DOI] 10.1111/ajad.13133.
2020
Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review.
Drug and alcohol dependence. 208 [DOI] 10.1016/j.drugalcdep.2020.107845. [PMID] 31978670.
2019
Antipsychotics for Amphetamine Psychosis. A Systematic Review.
Frontiers in psychiatry. 10 [DOI] 10.3389/fpsyt.2019.00740. [PMID] 31681046.
2018
Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation
Therapeutic Advances in Psychopharmacology. 8(5):147-168 [DOI] 10.1177/2045125317753340. [PMID] 29713452.
2018
Integrating DSM/ICD, Research Domain Criteria, and Descriptive Psychopathology in Teaching and Practice of Psychiatry.
Frontiers in psychiatry. 9 [DOI] 10.3389/fpsyt.2018.00484. [PMID] 30344498.
2017
Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of Kratom.
Frontiers in psychiatry. 8 [DOI] 10.3389/fpsyt.2017.00062. [PMID] 28484399.

Grants

Jul 2020 ACTIVE
Win-win: A University of Florida model for training addiction medicine fellows and incorporating behavioral healthcare into the primary care of the medically underserved
Role: Co-Project Director/Principal Investigator
Funding: US HLTH RESOURCES AND SERV ADMN

Education

Residency, Psychiatry
2010-2014 · Harlem Hospital Medical Center at Columbia University
Residency, Internal Medicine
1998-2001 · State University of Haiti Hospital
Medical School
1991-1997 · Université d'État d’Haïti

Contact Details

Phones:
Business:
(352) 265-4357
Emails:
Business:
fluyau.di@ufl.edu
Addresses:
Business Street:
4101 NW 89TH BLVD
GAINESVILLE FL 32606